Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
J. Streicher is a historic financial services and investment firm that maintains a specialized focus on the healthcare and life sciences industries. Founded in 1910 and originally serving as a prominent specialist on the New York Stock Exchange, the firm now provides a range of services including private equity, asset management, and capital markets advisory. In the life sciences sector, J. Streicher is particularly active in sponsoring healthcare-focused Special Purpose Acquisition Companies (SPACs) and providing growth capital to emerging biotech and medtech firms. The company leverages its extensive institutional heritage and global network to facilitate the commercialization of innovative medical technologies and therapies. By bridging the gap between scientific innovation and capital markets, J. Streicher plays a key role in the financial ecosystem of the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on J. Streicher.